- Home
- GEVO vs PSNL Comparison
GEVO vs PSNL Comparison
Compare GEVO & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- PSNL
- Stock Information
- Founded
- GEVO 2005
- PSNL 2011
- Country
- GEVO United States
- PSNL United States
- Employees
- GEVO N/A
- PSNL N/A
- Industry
- GEVO Major Chemicals
- PSNL Medical Specialities
- Sector
- GEVO Industrials
- PSNL Health Care
- Exchange
- GEVO Nasdaq
- PSNL Nasdaq
- Market Cap
- GEVO 498.2M
- PSNL 518.8M
- IPO Year
- GEVO 2011
- PSNL 2019
- Fundamental
- Price
- GEVO $2.14
- PSNL $7.34
- Analyst Decision
- GEVO Buy
- PSNL Strong Buy
- Analyst Count
- GEVO 2
- PSNL 4
- Target Price
- GEVO $8.13
- PSNL $8.13
- AVG Volume (30 Days)
- GEVO 6.3M
- PSNL 908.1K
- Earning Date
- GEVO 11-06-2025
- PSNL 11-05-2025
- Dividend Yield
- GEVO N/A
- PSNL N/A
- EPS Growth
- GEVO N/A
- PSNL N/A
- EPS
- GEVO N/A
- PSNL N/A
- Revenue
- GEVO $80,187,000.00
- PSNL $80,317,000.00
- Revenue This Year
- GEVO $909.99
- PSNL N/A
- Revenue Next Year
- GEVO $22.37
- PSNL $29.83
- P/E Ratio
- GEVO N/A
- PSNL N/A
- Revenue Growth
- GEVO 341.75
- PSNL 0.36
- 52 Week Low
- GEVO $0.92
- PSNL $2.83
- 52 Week High
- GEVO $3.39
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- GEVO 66.29
- PSNL 76.76
- Support Level
- GEVO $1.95
- PSNL $5.86
- Resistance Level
- GEVO $2.18
- PSNL $6.33
- Average True Range (ATR)
- GEVO 0.14
- PSNL 0.39
- MACD
- GEVO 0.00
- PSNL 0.12
- Stochastic Oscillator
- GEVO 77.78
- PSNL 96.88
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.